Pharmacological Group: Anti -Nemic, Active Principle: Follicic Acid, Pharmaceutical Form: Oral Solution, Concentration/Dosage: 0, 2, Unit: Mg/Ml, Volume: 30 Ml, Display, Accessory: N/A, Form Supply: Vial, Pharmacological Group: Antineoplastic, Active Principle: Cyclofosphamid, Pharmaceutical Form, Concentration / Dosage: 1, Unit: G, Volume: N / A, Presentation: Vial, Pharmaceutical Form: Drague, Concentration / Dosage: 50, Unit: Mg, Presentation: N / A, Active Principle: Citarabine Without Preservative, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 100, Volume: N / D, Active Principle: Dasatinib Pharmaceutical: Compressed, Concentration / Dosage: 20, 11/07/2025, Pharmaceutical Form: Tabletred Tablet, Form Supply: Unit, Active Principle: Melphalan, Concentration / Dosage: 2, Volume: Not Applicable, Introduction: Not Applied, Active Principle: Metotrexate, Concentration / Dosage: 25, 2Ml, 5, Active Principle, Active Principle: Active Principle: 2Ml Nilotinibe, Pharmaceutical Form: Capsule, Concentration / Dosage: 200
